25 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
efforts, at our sole cost and expense to oversee such commercialization efforts, to research, develop and commercialize products in one or more
8-K
57n3yh 9pfif0jcofi
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
8-K
EX-1.1
vkuvev95s
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
5hvtk6r0qjb1ls4
5 Oct 20
Prospectus supplement with pricing info
4:16pm